Pharmaceutical stocks were in the limelight this week with Merck's MRK CEO Ken Frazier resigning from President Donald Trump’s manufacturing council. The sector was also in the news with an investigation being launched into the …
Big pharma stocks have been popular among investors seeking solid dividends for a long time. And for good reason: Large drugmakers historically have generated such tremendous cash flow and earnings that they have been able to reward …